News

Tempus Announces Latest Immunotherapy Project

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, along with Georgetown Lombardi Comprehensive Cancer Center, in Washington, D.C., and John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center announce a new research collaboration aimed at identifying which patients will respond positively to immunotherapy treatment, the next generation of cancer care.

Read full article on globenewswire.com.